furazolidone has been researched along with Pneumonia in 4 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chernomordik, AB | 1 |
| Chaĭtsev, VG | 1 |
| Shesterenkina, VG | 1 |
| Voronin, SG | 1 |
| Dikarev, VF | 1 |
| Abkarovich, GF | 1 |
| Sherishorina, SI | 1 |
| Solodova, TL | 1 |
1 review available for furazolidone and Pneumonia
| Article | Year |
|---|---|
[Clinical use of furazolidone].
Topics: Dose-Response Relationship, Drug; Dysentery, Bacillary; Female; Furazolidone; Giardiasis; Humans; Ma | 1981 |
3 other studies available for furazolidone and Pneumonia
| Article | Year |
|---|---|
[Clinical etiological characteristics and the treatment of acute pneumonia].
Topics: Acute Disease; Drug Therapy, Combination; Furazolidone; Humans; Penicillins; Pneumonia | 1980 |
[Characteristic of the causative agents of acute pneumonia isolated from patients treated with antibiotics].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Chlortetracyclin | 1970 |
[A comparative study of the sensitivity of the agents of acute bacterial pneumonia to preparations of the nitrofuran series].
Topics: Acute Disease; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Furazolidone; Huma | 1970 |